PRESS RELEASE
TB Alliance Launches Combination Drug Trial, Establishes New Pathway to TB and MDR-TB Treatment
VIDEO
Christine Lubinski Introduction
Anthony Fauci Remarks
Janet Woodcock Remarks
Robert Clay Remarks
Mel Spigelman Remarks and News Announcement
Question and Answer session
PRESENTATIONS FROM LAUNCH EVENT
Mel Spigelman’s Presentation
Dr. Anthony Fauci’s Presentation
NC002 BACKGROUND
Novel Regimens: New Momentum in Finding Novel TB Cures
Accelerating New TB Regimens – Effective Coordination Across US Government
WORLD TB DAY PANEL EVENT AND NC002 ANNOUNCEMENT LAUNCH INFO
Monday, March 19, 2012 ** 1:30 – 3:00 PMBarbara Jordan Conference Center, Kaiser Family Foundation, 1330 G Street NW, Washington DC
Media Advisory: TB Alliance to Launch New Combination Drug Trial
DRAFT Event Agenda
SPEAKER BIOGRAPHIES
Dr. Anthony S. Fauci, Director, National Institute of Allergy and Infectious Diseases
Dr. Mel Spigelman, President and CEO, Global Alliance for TB Drug Development
Dr. Janet Woodcock, Director, US Food and Drug Administration’s Center for Drug Evaluation and Research
Dr. Robert Clay, Deputy Assistant Administrator, US Agency for International Development’s Global Health Bureau
Christine Lubinski, Vice President for Global Health, Infectious Diseases Society of America
VIDEOS
Dr. Anthony Fauci Invites you to Cure All
CPTR and the Promise of Regimen-Based Drug Development
Patient Story: A 7 Year-Old Battles MDR-TB
Lessons Learnt from MDR-TB Outbreak in New York City
PICTURES:
Download pictures, captions, and photo credits for media use